Synopsys, Inc. $SNPS Shares Sold by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd cut its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 84.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,723 shares of the semiconductor company’s stock after selling 54,845 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Synopsys were worth $4,683,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Principal Financial Group Inc. increased its stake in shares of Synopsys by 57.7% in the third quarter. Principal Financial Group Inc. now owns 412,766 shares of the semiconductor company’s stock valued at $203,654,000 after purchasing an additional 150,973 shares during the period. Mutual Advisors LLC grew its holdings in Synopsys by 2.1% in the 3rd quarter. Mutual Advisors LLC now owns 1,157 shares of the semiconductor company’s stock worth $528,000 after buying an additional 24 shares in the last quarter. UMB Bank n.a. increased its position in Synopsys by 14.4% in the 3rd quarter. UMB Bank n.a. now owns 787 shares of the semiconductor company’s stock valued at $388,000 after acquiring an additional 99 shares during the period. Transcend Capital Advisors LLC raised its stake in Synopsys by 37.6% during the 3rd quarter. Transcend Capital Advisors LLC now owns 2,785 shares of the semiconductor company’s stock valued at $1,374,000 after acquiring an additional 761 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its position in Synopsys by 111.9% during the 3rd quarter. Thrivent Financial for Lutherans now owns 14,689 shares of the semiconductor company’s stock worth $7,247,000 after acquiring an additional 7,756 shares during the period. Institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,157 shares of company stock worth $1,945,036 over the last three months. 0.62% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on SNPS shares. KeyCorp raised their price target on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Piper Sandler cut shares of Synopsys from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $602.00 to $520.00 in a research note on Tuesday, January 13th. Morgan Stanley boosted their price target on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Needham & Company LLC increased their price objective on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Finally, Bank of America raised Synopsys from an “underperform” rating to a “neutral” rating and dropped their target price for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $553.57.

View Our Latest Stock Analysis on SNPS

Synopsys Trading Down 1.6%

Shares of NASDAQ SNPS opened at $457.89 on Tuesday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company has a market cap of $87.60 billion, a price-to-earnings ratio of 57.31, a P/E/G ratio of 3.87 and a beta of 1.12. The business has a fifty day simple moving average of $478.60 and a 200-day simple moving average of $500.20.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm’s quarterly revenue was up 37.8% compared to the same quarter last year. During the same period last year, the firm posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.